Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
iX Biopharma Ltd. ( (SG:42C) ) has shared an update.
iX Biopharma Ltd. has announced the maturity date for its S$2,000,000 convertible bonds, which will mature on July 24, 2025. The conversion period will end on June 23, 2025, and the bonds can be converted into new ordinary shares at a conversion price of S$0.12 per share. In the event of a takeover offer, the conversion price may be adjusted but will not fall below S$0.07. This announcement provides clarity on the financial instruments available to stakeholders and may impact the company’s financial strategy and shareholder value.
More about iX Biopharma Ltd.
iX Biopharma Ltd. is a company incorporated in Singapore, operating in the biopharmaceutical industry. The company focuses on developing and commercializing innovative therapies and products, with a market focus on healthcare solutions.
Average Trading Volume: 241,313
Technical Sentiment Signal: Sell
Current Market Cap: S$15.1M
For a thorough assessment of 42C stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue